Literature DB >> 11786491

Multiple mechanisms of vascular smooth muscle relaxation by the activation of proteinase-activated receptor 2 in mouse mesenteric arterioles.

John J McGuire1, Morley D Hollenberg, Patricia Andrade-Gordon, Chris R Triggle.   

Abstract

1. Activation of PAR2 in second-order mesenteric arteriole (MA) rings from C57BL/6J, NOS3 (-/-) and PAR2 (-/-) mice was assessed for the contributions of NO, cyclo-oxygenases, guanylyl cyclase, adenylyl cyclase, and of K(+) channel activation to vascular smooth muscle relaxation. 2. PAR2 agonist, SLIGRL-NH(2) (0.1 to 30 microM), induced relaxation of cirazoline-precontracted MA from C57BL/6J and NOS3 (-/-), but not PAR2 (-/-) mice. Maximal relaxation (E(max)) was partially reduced by a combination of L-(G)N-nitroarginine methyl ester (L-NAME), 1H-[1,2,4]-oxadiazolo[4,3-a]quinoxalin-1-one (ODQ) and indomethacin. An ODQ/L-NAME/indomethacin resistant relaxation was also caused by trypsin (30 nM) in PAR2 (+/+), but not in PAR2 (-/-) mice. Relaxation was endothelium-dependent and inhibited by either 30 mM KCl-precontraction, or pretreatment with apamin, charybdotoxin, and their combination; iberiotoxin did not substitute for charybdotoxin nor did scyllatoxin substitute fully for apamin. 3. Tetraethylammonium (TEA), glibenclamide, tetrodotoxin, 17-octadecynoic acid, carboxy-2-phenyl-4,4,5,5,-tetramethyl-imidazoline-1-oxyl-3-oxide, SQ22536, carbenoxolone, arachidonyl trifluoromethyl ketone, 7-nitroindazole, N-(3-(aminomethyl)benzyl)acetamidine (1400W), N-(2-cyclohexyloxy-4-nitrophenyl)-methanesulfonamide (NS-398) and propanolol did not inhibit relaxation. 4-aminopyridine significantly increased the potency of SLIGRL-NH(2). A combination of 30 microM BaCl(2) and 10 microM ouabain significantly reduced the potency for relaxation, and in the presence of L-NAME, ODQ and indomethacin, E(max) was reduced. 4. We conclude PAR2-mediated relaxation of mouse MA utilizes multiple mechanisms that are both NO-cGMP-dependent, and -independent. The data are also consistent with a role for endothelium-dependent hyperpolarization of vascular smooth muscle that involves the activation of an apamin/charybdotoxin-sensitive K(+) channel(s) and, in part, may be mediated by K(+).

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11786491      PMCID: PMC1573127          DOI: 10.1038/sj.bjp.0704469

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  74 in total

1.  Mechanisms of endothelium-dependent vascular smooth muscle relaxation elicited by bradykinin and VIP.

Authors:  L J Ignarro; R E Byrns; G M Buga; K S Wood
Journal:  Am J Physiol       Date:  1987-11

2.  Proteinase-activated receptor 4 (PAR4): activation and inhibition of rat platelet aggregation by PAR4-derived peptides.

Authors:  M D Hollenberg; M Saifeddine
Journal:  Can J Physiol Pharmacol       Date:  2001-05       Impact factor: 2.273

3.  K+ channels which contribute to the acetylcholine-induced hyperpolarization in smooth muscle of the guinea-pig submucosal arteriole.

Authors:  H Hashitani; H Suzuki
Journal:  J Physiol       Date:  1997-06-01       Impact factor: 5.182

4.  Molecular cloning of a potential proteinase activated receptor.

Authors:  S Nystedt; K Emilsson; C Wahlestedt; J Sundelin
Journal:  Proc Natl Acad Sci U S A       Date:  1994-09-27       Impact factor: 11.205

5.  Rat proteinase-activated receptor-2 (PAR-2): cDNA sequence and activity of receptor-derived peptides in gastric and vascular tissue.

Authors:  M Saifeddine; B al-Ani; C H Cheng; L Wang; M D Hollenberg
Journal:  Br J Pharmacol       Date:  1996-06       Impact factor: 8.739

6.  Heterogeneous mechanisms of endothelium-dependent relaxation for thrombin and peptide activators of protease-activated receptor-1 in porcine isolated coronary artery.

Authors:  J R Hamilton; T M Cocks
Journal:  Br J Pharmacol       Date:  2000-05       Impact factor: 8.739

7.  Ligand cross-reactivity within the protease-activated receptor family.

Authors:  B D Blackhart; K Emilsson; D Nguyen; W Teng; A J Martelli; S Nystedt; J Sundelin; R M Scarborough
Journal:  J Biol Chem       Date:  1996-07-12       Impact factor: 5.157

8.  Endothelium-dependent contractile actions of proteinase-activated receptor-2-activating peptides in human umbilical vein: release of a contracting factor via a novel receptor.

Authors:  M Saifeddine; S S Roy; B Al-Ani; C R Triggle; M D Hollenberg
Journal:  Br J Pharmacol       Date:  1998-12       Impact factor: 8.739

9.  Endothelium-dependent and -independent responses to protease-activated receptor-2 (PAR-2) activation in mouse isolated renal arteries.

Authors:  J D Moffatt; T M Cocks
Journal:  Br J Pharmacol       Date:  1998-10       Impact factor: 8.739

10.  Hyperpolarization and relaxation of arterial smooth muscle caused by nitric oxide derived from the endothelium.

Authors:  M Tare; H C Parkington; H A Coleman; T O Neild; G J Dusting
Journal:  Nature       Date:  1990-07-05       Impact factor: 49.962

View more
  25 in total

Review 1.  Cardiovascular impact of drugs used in the treatment of diabetes.

Authors:  Chris R Triggle; Hong Ding
Journal:  Ther Adv Chronic Dis       Date:  2014-11       Impact factor: 5.091

2.  Proteinase-activated receptor 2 activation modulates guinea-pig mesenteric lymphatic vessel pacemaker potential and contractile activity.

Authors:  Alice K Chan; Nathalie Vergnolle; Morley D Hollenberg; Pierre-Yves von der Weid
Journal:  J Physiol       Date:  2004-08-26       Impact factor: 5.182

3.  Proteinase-activated receptors 1 and 2 and the regulation of porcine coronary artery contractility: a role for distinct tyrosine kinase pathways.

Authors:  Mahmoud El-Daly; Mahmoud Saifeddine; Koichiro Mihara; Rithwik Ramachandran; Christopher R Triggle; Morley D Hollenberg
Journal:  Br J Pharmacol       Date:  2014-05       Impact factor: 8.739

Review 4.  Endothelium-derived hyperpolarising factors and associated pathways: a synopsis.

Authors:  Gillian Edwards; Michel Félétou; Arthur H Weston
Journal:  Pflugers Arch       Date:  2010-04-11       Impact factor: 3.657

5.  Endothelial alkalinisation inhibits gap junction communication and endothelium-derived hyperpolarisations in mouse mesenteric arteries.

Authors:  Ebbe Boedtkjer; Sukhan Kim; Christian Aalkjaer
Journal:  J Physiol       Date:  2013-01-07       Impact factor: 5.182

6.  Heat shock protein-27 and sex-selective regulation of muscarinic and proteinase-activated receptor 2-mediated vasodilatation: differential sensitivity to endothelial NOS inhibition.

Authors:  Vivek Krishna Pulakazhi Venu; Mahmoud Saifeddine; Koichiro Mihara; Mahmoud El-Daly; Darrell Belke; Jonathan L E Dean; Edward R O'Brien; Simon A Hirota; Morley D Hollenberg
Journal:  Br J Pharmacol       Date:  2018-04-25       Impact factor: 8.739

7.  β-Arrestin-2 mediates the proinflammatory effects of proteinase-activated receptor-2 in the airway.

Authors:  Heddie L Nichols; Mahmoud Saffeddine; Barbara S Theriot; Akhil Hegde; Daniel Polley; Tamer El-Mays; Harissios Vliagoftis; Morley D Hollenberg; Emma H Wilson; Julia K L Walker; Kathryn A DeFea
Journal:  Proc Natl Acad Sci U S A       Date:  2012-09-25       Impact factor: 11.205

8.  Involvement of EDHF in the hypotension and increased gastric mucosal blood flow caused by PAR-2 activation in rats.

Authors:  Atsufumi Kawabata; Yumiko Nakaya; Ryotaro Kuroda; Mariko Wakisaka; Takashi Masuko; Hiroyuki Nishikawa; Kenzo Kawai
Journal:  Br J Pharmacol       Date:  2003-08-04       Impact factor: 8.739

9.  Protease activated receptors in cardiovascular function and disease.

Authors:  Junor A Barnes; Shamjeet Singh; Aldrin V Gomes
Journal:  Mol Cell Biochem       Date:  2004-08       Impact factor: 3.396

10.  Proteinase-activated receptor-4: evaluation of tethered ligand-derived peptides as probes for receptor function and as inflammatory agonists in vivo.

Authors:  Morley D Hollenberg; Mahmoud Saifeddine; Sabrina Sandhu; Steeve Houle; Nathalie Vergnolle
Journal:  Br J Pharmacol       Date:  2004-09-27       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.